Since 1992, CoaguChek® by Roche Diagnostics, has led the way in Point of Care (POC) testing, developing innovative solutions in coagulation monitoring for both professionals and patients alike. As a market leader in POC International Normalized Ratio (INR) monitoring solutions, CoaguChek®, has played a vital role in anticoagulation therapy, particularly for patients on Vitamin K Antagonist (VKA) medications such as warfarin.
Patient Self Testing of INR has emerged as a resounding success story. Patients managed with POC testing achieve a higher time in therapeutic range and fewer values out of range compared with patients treated with usual care.1-3 This results in fewer treatment-related complications,4,5 fewer hospitalizations and emergency department visits,4,5 and improved patient satisfaction.6-8
Despite the advent of Direct Oral Anticoagulants (DOACs), which have become the preferred choice for many patients, there remains a crucial segment for whom DOACs are not suitable. For these patients, CoaguChek® continues to be the cost-effective and proven INR monitoring solution, ensuring reliable and personalized care.
Performed by healthcare professionals immediately at the patient's point of care. CoaguChek® offers reliable and easy-to-use solutions that provide immediate results, allowing treatment decisions to be made promptly.
References
